Women with polycystic ovary syndrome (PCOS) are often insulin resistant and have chronic low-level inflammation. The purpose of this study was to determine the effects of hyperglycemia in vitro on tumor necrosis factor (TNF)-release from mononuclear cells (MNC) in PCOS. Twelve reproductive-age women with PCOS (six lean, six obese) and 12 age-matched controls (six lean, six obese) were studied. Insulin sensitivity (IS HOMA ) was estimated from fasting levels of glucose and insulin and percent truncal fat was determined by dual energy absorptiometry (DEXA). TNF release was measured from MNC cultured under euglycemic and hyperglycemic conditions. IS HOMA was higher in obese women with PCOS than in lean women with PCOS (student's t-test; 73路7 14路8 vs 43路1 8路6, P<0路05), but similar to that of obese controls. IS HOMA was positively correlated with percent truncal fat (r=0路57, P<0路04). Obese women with PCOS exhibited an increase in the percent change in TNF release from MNC in response to hyperglycemia compared with obese controls (10 mM, 649 208% vs 133 30%, P<0路003; 15 mM, 799 347% vs 183 59%, P<0路04). The TNF response directly correlated with percent truncal fat (r=0路45, P<0路03) and IS HOMA (r=0路40, P<0路05) for the combined groups, and with plasma testosterone (r=0路60, P<0路05) for women with PCOS. MNC of obese women with PCOS exhibit an increased TNF response to in vitro physiologic hyperglycemia. MNC-derived TNF release may contribute to insulin resistance and hyperandrogenism, particularly when the combination of PCOS and increased adiposity is present.